349 related articles for article (PubMed ID: 18674740)
1. In vitro studies of amikacin-loaded human carrier erythrocytes.
Gutiérrez Millán C; Bax BE; Castañeda AZ; Marinero ML; Lanao JM
Transl Res; 2008 Aug; 152(2):59-66. PubMed ID: 18674740
[TBL] [Abstract][Full Text] [Related]
2. Study of the factors influencing the encapsulation of zidovudine in rat erythrocytes.
Briones E; Colino CI; Lanao JM
Int J Pharm; 2010 Nov; 401(1-2):41-6. PubMed ID: 20854886
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and biodistribution of amikacin encapsulated in carrier erythrocytes.
Gutiérrez Millán C; Zarzuelo Castañeda A; González López F; Sayalero Marinero ML; Lanao JM
J Antimicrob Chemother; 2008 Feb; 61(2):375-81. PubMed ID: 18096557
[TBL] [Abstract][Full Text] [Related]
4. Encapsulation and in vitro evaluation of amikacin-loaded erythrocytes.
Millán CG; Castañeda AZ; López FG; Marinero ML; Lanao JM; Arévalo M
Drug Deliv; 2005; 12(6):409-16. PubMed ID: 16253957
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in-vitro characterization of tramadol-loaded carrier erythrocytes for long-term intravenous delivery.
Foroozesh M; Hamidi M; Zarrin A; Mohammadi-Samani S; Montaseri H
J Pharm Pharmacol; 2011 Mar; 63(3):322-32. PubMed ID: 21749379
[TBL] [Abstract][Full Text] [Related]
6. Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study.
Alanazi FK; Harisa Gel-D; Maqboul A; Abdel-Hamid M; Neau SH; Alsarra IA
Arch Pharm Res; 2011 Apr; 34(4):563-71. PubMed ID: 21544721
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery.
Hamidi M; Zarei N; Zarrin AH; Mohammadi-Samani S
Int J Pharm; 2007 Jun; 338(1-2):70-8. PubMed ID: 17317049
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte based delivery system of primaquine: in vitro characterization.
Talwar N; Jain NK
J Microencapsul; 1992; 9(3):357-64. PubMed ID: 1403486
[TBL] [Abstract][Full Text] [Related]
9. Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes.
Briones E; Colino CI; Millán CG; Lanao JM
Eur J Pharm Sci; 2009 Nov; 38(4):320-4. PubMed ID: 19712742
[TBL] [Abstract][Full Text] [Related]
10. Erythrocytes as carrier for prednisolone: in vitro and in vivo evaluation.
Shavi GV; Doijad RC; Deshpande PB; Manvi FV; Meka SR; Udupa N; Omprakash R; Dhirendra K
Pak J Pharm Sci; 2010 Apr; 23(2):194-200. PubMed ID: 20363699
[TBL] [Abstract][Full Text] [Related]
11. Some effects of the trypanocidal drug isometamidium on encapsulation in bovine carrier erythrocytes.
DeLoach JR; Wagner GG
Biotechnol Appl Biochem; 1988 Oct; 10(5):447-53. PubMed ID: 3196446
[TBL] [Abstract][Full Text] [Related]
12. Survival of human carrier erythrocytes in vivo.
Bax BE; Bain MD; Talbot PJ; Parker-Williams EJ; Chalmers RA
Clin Sci (Lond); 1999 Feb; 96(2):171-8. PubMed ID: 9918897
[TBL] [Abstract][Full Text] [Related]
13. Osmotic fragility of drug carrier erythrocytes.
Sprandel U; Zöllner N
Res Exp Med (Berl); 1985; 185(1):77-85. PubMed ID: 3969524
[TBL] [Abstract][Full Text] [Related]
14. A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency.
Bax BE; Bain MD; Fairbanks LD; Webster AD; Ind PW; Hershfield MS; Chalmers RA
Eur J Haematol; 2007 Oct; 79(4):338-48. PubMed ID: 17680812
[TBL] [Abstract][Full Text] [Related]
15. Interaction of carboplatin with carrier human erythrocytes.
Tonetti M; Gasparini A; Giovine M; Bini D; Mazzucotelli A; De Paz F; Benatti U; De Flora A
Biotechnol Appl Biochem; 1992 Jun; 15(3):267-77. PubMed ID: 1388819
[TBL] [Abstract][Full Text] [Related]
16. The effects of mefenamic acid on the osmotic fragility of lacertilian erythrocytes.
Ahmad M; Hasan R; Qureshi A; Ahmad M; Ahmed Z
Pak J Pharm Sci; 2005 Apr; 18(2):14-8. PubMed ID: 16431392
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b.
Hamidi M; Zarrin AH; Foroozesh M; Zarei N; Mohammadi-Samani S
Int J Pharm; 2007 Aug; 341(1-2):125-33. PubMed ID: 17512685
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human erythrocytes as potential carrier for pravastatin: an in vitro study.
Harisa Gel-D; Ibrahim MF; Alanazi FK
Int J Med Sci; 2011 Mar; 8(3):222-30. PubMed ID: 21448309
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte-mediated delivery of pravastatin: in vitro study of effect of hypotonic lysis on biochemical parameters and loading efficiency.
Harisa GI; Ibrahim MF; Alanazi FK
Arch Pharm Res; 2012 Aug; 35(8):1431-9. PubMed ID: 22941486
[TBL] [Abstract][Full Text] [Related]
20. Osmotic fragility of the erythrocyte membrane: characterization by modeling of the transmittance curve as a function of the NaCl concentration.
Didelon J; Mazeron P; Muller S; Stoltz JF
Biorheology; 2000; 37(5-6):409-16. PubMed ID: 11204546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
